High LAT1 expression is associated with poor prognosis and shorter progression-free survival in various cancers (e.g. ovarian cancer, pancreatic cancer, adenoid, cystic cancer, lung neuroendocrine tumours) [38–45]. This evidence concerns the gene SLC7A5 and familial pancreatic carcinoma.